Capital Fund Management S.A. Invests $1.49 Million in Schrodinger, Inc. $SDGR

Capital Fund Management S.A. acquired a new position in Schrodinger, Inc. (NASDAQ:SDGR) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 73,838 shares of the company’s stock, valued at approximately $1,486,000.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. Geneos Wealth Management Inc. raised its position in shares of Schrodinger by 41.6% during the first quarter. Geneos Wealth Management Inc. now owns 84,943 shares of the company’s stock valued at $1,677,000 after buying an additional 24,947 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Schrodinger by 169.0% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,357,532 shares of the company’s stock worth $86,018,000 after buying an additional 2,737,728 shares in the last quarter. Perigon Wealth Management LLC bought a new position in Schrodinger during the second quarter valued at about $294,000. Slow Capital Inc. acquired a new position in Schrodinger in the 2nd quarter valued at approximately $2,085,000. Finally, Allspring Global Investments Holdings LLC raised its holdings in Schrodinger by 17.7% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 205,319 shares of the company’s stock valued at $4,131,000 after acquiring an additional 30,948 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Activity

In other news, insider Margaret Dugan sold 1,395 shares of Schrodinger stock in a transaction that occurred on Thursday, October 16th. The shares were sold at an average price of $21.07, for a total value of $29,392.65. Following the completion of the transaction, the insider owned 24,574 shares in the company, valued at approximately $517,774.18. The trade was a 5.37% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 21.00% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently weighed in on SDGR. Morgan Stanley decreased their price objective on Schrodinger from $28.00 to $19.00 and set an “equal weight” rating on the stock in a report on Monday, August 18th. The Goldman Sachs Group initiated coverage on shares of Schrodinger in a research note on Monday, September 29th. They set a “neutral” rating and a $19.00 price target on the stock. KeyCorp dropped their price objective on shares of Schrodinger from $30.00 to $28.00 and set an “overweight” rating for the company in a research note on Wednesday, October 8th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Schrodinger in a report on Tuesday, October 14th. Finally, Wall Street Zen raised shares of Schrodinger from a “sell” rating to a “hold” rating in a research note on Saturday, October 25th. Three research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $26.00.

Schrodinger Stock Performance

Shares of NASDAQ SDGR opened at $18.42 on Friday. Schrodinger, Inc. has a 52-week low of $15.99 and a 52-week high of $28.47. The business has a fifty day moving average of $19.32 and a two-hundred day moving average of $20.25. The stock has a market cap of $1.36 billion, a PE ratio of -7.64 and a beta of 1.56.

Schrodinger (NASDAQ:SDGR) last announced its earnings results on Wednesday, November 5th. The company reported ($0.45) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.72) by $0.27. Schrodinger had a negative net margin of 68.49% and a negative return on equity of 48.24%. The business had revenue of $54.32 million during the quarter, compared to analysts’ expectations of $50.51 million. During the same quarter last year, the company posted ($0.87) EPS. The firm’s revenue for the quarter was up 53.9% on a year-over-year basis. Analysts predict that Schrodinger, Inc. will post -2.37 earnings per share for the current year.

About Schrodinger

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.